Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak. Stringhini S, Zaballa ME, Perez-Saez J, Pullen N, et al. Lancet Infect Dis 2021 Feb 1. pii: S1473-3099(21)00054.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Stringhini S, Zaballa ME, Perez-Saez J, Pullen N, et al. Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak. Lancet Infect Dis 2021 Feb 1. pii: S1473-3099(21)00054.
PMID: 33539733